loadpatents
name:-0.082505941390991
name:-0.089308023452759
name:-0.023419141769409
Rajpal; Arvind Patent Filings

Rajpal; Arvind

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rajpal; Arvind.The latest application filed is for "psgl-1 antagonists and uses thereof".

Company Profile
16.41.69
  • Rajpal; Arvind - San Francisco CA
  • Rajpal; Arvind - South San Francisco CA
  • Rajpal; Arvind - Chesterfield MO
  • Rajpal; Arvind - Stonington CT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
PSGL-1 Antagonists and Uses Thereof
App 20220298258 - Johnston; Robert J. ;   et al.
2022-09-22
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20220249657 - Abdiche; Yasmina Noubia ;   et al.
2022-08-11
Heterodimeric proteins and methods for producing and purifying them
Grant 11,390,689 - Ho , et al. July 19, 2
2022-07-19
Ipilimumab Variants With Enhanced Specificity For Binding At Low Ph
App 20220193237 - LEE; Peter Sung Keun ;   et al.
2022-06-23
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20220175921 - WANG; Changyu ;   et al.
2022-06-09
Anti-PD-1 antibodies and methods of use thereof
Grant 11,338,035 - Abdiche , et al. May 24, 2
2022-05-24
Chimeric antigen receptors targeting B-cell maturation antigen
Grant 11,312,782 - Kuo , et al. April 26, 2
2022-04-26
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
Grant 11,306,150 - Johnston , et al. April 19, 2
2022-04-19
Antibodies Binding to Vista at Acidic pH
App 20220073617 - Johnston; Robert J. ;   et al.
2022-03-10
Inhibitory Chimeric Antigen Receptors
App 20220033462 - RAJPAL; ARVIND ;   et al.
2022-02-03
Binding Molecules To The Human Ox40 Receptor
App 20220002428 - MIN; Jing ;   et al.
2022-01-06
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
Grant 11,213,586 - Wang , et al. January 4, 2
2022-01-04
Therapeutic antibodies and their uses
Grant 11,155,630 - Kuo , et al. October 26, 2
2021-10-26
Antibodies specific for Trop-2 and their uses
Grant 11,091,544 - Liu , et al. August 17, 2
2021-08-17
Inhibitory chimeric antigen receptors
Grant 11,072,644 - Rajpal , et al. July 27, 2
2021-07-27
Therapeutic Antibodies And Their Uses
App 20210188991 - KUO; Tracy Chia-Chien ;   et al.
2021-06-24
Anti-CLL1 specific single-chain chimeric antigen receptors (scCARs) for cancer immunotherapy
Grant 11,014,989 - Smith , et al. May 25, 2
2021-05-25
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20210115159 - STROP; Pavel ;   et al.
2021-04-22
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
Grant 10,941,216 - Strop , et al. March 9, 2
2021-03-09
Therapeutic Antibodies And Their Uses
App 20210054087 - KUO; Tracy Chia-Chien ;   et al.
2021-02-25
Antibodies Binding to Vista at Acidic pH
App 20210017283 - Johnston; Robert J. ;   et al.
2021-01-21
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20200368349 - Abdiche; Yasmina Noubia ;   et al.
2020-11-26
Therapeutic antibodies and their uses
Grant 10,793,635 - Kuo , et al. October 6, 2
2020-10-06
Antibodies Comprising Modified Heavy Constant Regions
App 20200299400 - LONBERG; Nils ;   et al.
2020-09-24
Antibodies Comprising Modified Heavy Constant Regions
App 20200268901 - LONBERG; Nils ;   et al.
2020-08-27
Anti-PD-1 antibodies and methods of use thereof
Grant 10,660,953 - Abdiche , et al.
2020-05-26
Antibodies comprising modified heavy constant regions
Grant 10,653,791 - Lonberg , et al.
2020-05-19
Antibodies Binding to VISTA at Acidic pH
App 20200055936 - Johnston; Robert J. ;   et al.
2020-02-20
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
App 20200024366 - PONS; Jaume ;   et al.
2020-01-23
PSGL-1 Antagonists and Uses Thereof
App 20190330364 - Johnston; Robert J. ;   et al.
2019-10-31
A Method Of Engineering Prodrug-specific Hypersensitive T-cells For Immunotherapy By Gene Expression
App 20190328783 - VALTON; Julien ;   et al.
2019-10-31
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
App 20190241669 - KUO; Tracy Chia-Chien ;   et al.
2019-08-08
Chimeric antigen receptors targeting B-cell maturation antigen
Grant 10,294,304 - Kuo , et al.
2019-05-21
Binding Molecules To The Human Ox40 Receptor
App 20190135932 - MIN; Jing ;   et al.
2019-05-09
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20190100603 - HO; Weihsien ;   et al.
2019-04-04
Prodruggable Antibodies, Prodrugs Thereof, And Methods Of Use And Making
App 20190055321 - Krystek, JR.; Stanley R. ;   et al.
2019-02-21
Binding molecules to the human OX40 receptor
Grant 10,196,452 - Min , et al. Fe
2019-02-05
Antibodies Specific For Trop-2 And Their Uses
App 20190002559 - Liu; Shu-Hui ;   et al.
2019-01-03
Variant Antibodies For Site-specific Conjugation
App 20180362619 - SHEPPARD; Paul O. ;   et al.
2018-12-20
Anti-PD-1 antibodies and methods of use thereof
Grant 10,155,037 - Abdiche , et al. Dec
2018-12-18
Antibodies Against Glucocorticoid-induced Tumor Necrosis Factor Receptor (gitr) And Uses Thereof
App 20180339042 - WANG; Changyu ;   et al.
2018-11-29
Heterodimeric proteins and methods for producing and purifying them
Grant 10,138,303 - Ho , et al. Nov
2018-11-27
Antibodies Comprising Modified Heavy Constant Regions
App 20180333502 - LONBERG; Nils ;   et al.
2018-11-22
Therapeutic Antibodies And Their Uses
App 20180298108 - KUO; Tracy Chia-Chien ;   et al.
2018-10-18
Antibodies specific for TROP-2 and their uses
Grant 10,100,114 - Liu , et al. October 16, 2
2018-10-16
Antibodies Against Ox40 And Uses Thereof
App 20180237534 - CAI; Zhehong ;   et al.
2018-08-23
Therapeutic antibodies and their uses
Grant 10,040,860 - Kuo , et al. August 7, 2
2018-08-07
Therapeutic Antibodies And Their Uses
App 20180171018 - KUO; Tracy Chia-Chien ;   et al.
2018-06-21
Therapeutic antibodies and their uses
Grant 9,969,809 - Kuo , et al. May 15, 2
2018-05-15
Binding Molecules To The Human Ox40 Receptor
App 20180057600 - MIN; Jing ;   et al.
2018-03-01
T Cell Receptor Knock Out Engineered Immune Cells, Endowed With Chimeric Antigen Receptors Binding To Cd123 For The Treatment Of Relapsed/refractory Acute Myeloid Lymphoma Or Blastic Plasmacytoid Dendritic Cell Neoplasm
App 20180051089 - GALETTO; Roman ;   et al.
2018-02-22
Inhibitory Chimeric Antigen Receptors
App 20180044399 - RAJPAL; Arvind ;   et al.
2018-02-15
Anti-cll1 Specific Single-chain Chimeric Antigen Receptors (sccars) For Cancer Immunotherapy
App 20180009895 - SMITH; Julianne ;   et al.
2018-01-11
Anti-hsp70 Specific Chimeric Antigen Receptors (cars) For Cancer Immunotherapy
App 20180000914 - VALTON; Julien ;   et al.
2018-01-04
mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS
App 20180002435 - SASU; Barbara Johnson ;   et al.
2018-01-04
Cll1-specific Multi-chain Chimeric Antigen Receptor
App 20180002427 - SMITH; Julianne ;   et al.
2018-01-04
Binding molecules to the human OX40 receptor
Grant 9,840,562 - Min , et al. December 12, 2
2017-12-12
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20170313787 - STROP; Pavel ;   et al.
2017-11-02
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
Grant 9,676,871 - Strop , et al. June 13, 2
2017-06-13
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20170058054 - HO; Weihsien ;   et al.
2017-03-02
Antibody-drug Conjugates With High Drug Loading
App 20170043033 - STROP; Pavel ;   et al.
2017-02-16
Heterodimeric proteins and methods for producing and purifying them
Grant 9,527,926 - Ho , et al. December 27, 2
2016-12-27
Antibodies Against Ox40 And Uses Thereof
App 20160347849 - CAI; Zhehong ;   et al.
2016-12-01
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
App 20160297884 - KUO; TRACY CHIA-CHIEN ;   et al.
2016-10-13
Therapeutic Antibodies And Their Uses
App 20160297885 - KUO; Tracy Chia-Chien ;   et al.
2016-10-13
Antibodies Specific For Trop-2 And Their Uses
App 20160257746 - LIU; Shu-Hui ;   et al.
2016-09-08
Antibodies specific for trop-2 and their uses
Grant 9,399,074 - Liu , et al. July 26, 2
2016-07-26
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20160159905 - ABDICHE; Yasmina Noubia ;   et al.
2016-06-09
Nucleic acids encoding antibodies to CCR2
Grant 9,238,691 - Gladue , et al. January 19, 2
2016-01-19
ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING
App 20150266974 - PONS; Jaume ;   et al.
2015-09-24
Binding Molecules To The Human Ox40 Receptor
App 20150218279 - Min; Jing ;   et al.
2015-08-06
Antibodies To Il-6 And Their Uses
App 20150203574 - Rajpal; Arvind ;   et al.
2015-07-23
Binding molecules to the human OX40 receptor
Grant 9,028,824 - Min , et al. May 12, 2
2015-05-12
Anti-PCSK9 antibodies with pH dependent antigen binding
Grant 9,029,515 - Pons , et al. May 12, 2
2015-05-12
Antibodies Specific For Trop-2 And Their Uses
App 20140357844 - LIU; Shu-Hui ;   et al.
2014-12-04
Antibodies To Ccr2
App 20140342450 - Gladue; Ronald P. ;   et al.
2014-11-20
Antibodies specific for Trop-2 and their uses
Grant 8,871,908 - Liu , et al. October 28, 2
2014-10-28
Antibodies to IL-6 and their uses
Grant 8,846,037 - Rajpal , et al. September 30, 2
2014-09-30
Antibodies to CCR2
Grant 8,710,191 - Gladue , et al. April 29, 2
2014-04-29
Antibodies To Il-6 And Their Uses
App 20130280266 - Rajpal; Arvind ;   et al.
2013-10-24
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20130230543 - Pons; Jaume ;   et al.
2013-09-05
Antibodies Specific For Trop-2 And Their Uses
App 20130122020 - LIU; Shu-Hui ;   et al.
2013-05-16
Heterodimeric Proteins And Methods For Producing And Purifying Them
App 20130115208 - Ho; Wei-Hsien ;   et al.
2013-05-09
Antibodies to IL-6 and their uses
Grant 8,436,158 - Rajpal , et al. May 7, 2
2013-05-07
Binding Molecules To The Human Ox40 Receptor
App 20120225086 - Min; Jing ;   et al.
2012-09-06
Antibodies To Il-6 And Their Uses
App 20120202285 - Rajpal; Arvind ;   et al.
2012-08-09
Binding molecules to the human OX40 receptor
Grant 8,236,930 - Min , et al. August 7, 2
2012-08-07
Antibodies to IL-6 and their uses
Grant 8,188,235 - Rajpal , et al. May 29, 2
2012-05-29
Method Of Producing Human Igg Antibodies With Enhanced Effector Functions
App 20120107871 - Crea; Roberto ;   et al.
2012-05-03
Antibodies To Ccr2
App 20110274696 - Gladue; Ronald P. ;   et al.
2011-11-10
Universal Antibody Libraries
App 20110245108 - Crea; Roberto ;   et al.
2011-10-06
Antibodies with pH Dependent Antigen Binding
App 20110229489 - Pons; Jaume ;   et al.
2011-09-22
Binding Molecules To The Human Ox40 Receptor
App 20110206681 - Min; Jing ;   et al.
2011-08-25
Binding molecules to the human OX40 receptor
Grant 7,960,515 - Min , et al. June 14, 2
2011-06-14
ANTI IgE ANTIBODIES
App 20110064726 - Liu; Wai ;   et al.
2011-03-17
Anti-IgE antibodies
Grant 7,867,494 - Liu , et al. January 11, 2
2011-01-11
Antibodies To Il-6 And Their Uses
App 20090317402 - Rajpal; Arvind ;   et al.
2009-12-24
Method of Producing Human IgG Antibodies with Enhanced Effector Functions
App 20090215639 - Crea; Roberto ;   et al.
2009-08-27
Binding Molecules To The Human Ox40 Receptor
App 20090214560 - Min; Jing ;   et al.
2009-08-27
Anti-IgE antibodies
App 20090117124 - Liu; Wai ;   et al.
2009-05-07
High affinity anti-TNF-alpha antibodies and method
App 20060024308 - Crea; Roberto ;   et al.
2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed